Dr. Philip Bonomi MD
USINFO | 2013-11-28 14:49
Medical Oncologist
Contact Information
1725 W Harrison St
Suite 855
Chicago, IL 60612
Phone: (312) 942-5904
Specialty & Clinical Interests
Medical Oncologist: General Oncology
Hospital Affiliation
Rush University Medical Center
High performing in Cancer
Education & Medical Training
Geisinger Health System
Residency, Internal Medicine, 1971 - 1972
Geisinger Health System
Residency, Internal Medicine, 1974 - 1975
Rush University Medical Center
Fellowship, Medical Oncology, 1975 - 1977
Geisinger Health System
Internship, Transitional Year, 1970 - 1971
University of Illinois College of Medicine
Class of 1970
Certifications & Licensure
American Board of Internal Medicine
Certified 2014 years in Internal Medicine
American Board of Internal Medicine
Certified 2014 years in Medical Oncology
IL State Medical License
Active through 2014
Awards, Honors & Recognition
CMS Stage 1 2012, Centers for Medicare & Medicaid Services
2011
Publications & Presentations
Prognostic significance of weight gain during definitive chemoradiotherapy for locally advanced non-small-cell lung cancer.
Sher, D. J.,Gielda, B. T.,Liptay, M. J.,Warren, W. H.,Batus, M.,Fidler, M. J.,Garg, S.,Bonomi, P.
Randomized Phase II Study of Cetuximab and Bevacizumab in Combination with Two Regimens of Paclitaxel and Carboplatin in Chemonaive Patients with Stage IIIB/IV Non-Small-Cell Lung Cancer.
Bonomi, P. D.,Mace, J.,Mandanas, R. A.,Min, M.,Olsen, M.,Youssoufian, H.,Katz, T. L.,Sheth, G.,Lee, H. J.
CDKN2A (p16) Promoter Hypermethylation Influences the Outcome in Young Lung Cancer Patients.
Bradly, D. P., Gattuso, P., Pool, M., Basu, S., Liptay, M., Bonomi, P., Buckingham, L.
Share this page